Advertisement

Topics

Plaque Psoriasis Pipeline Insight, 2017 [Report Updated: 31072017] Prices from USD $1250

01:28 EDT 10 Aug 2017 | BioPortfolio Reports

DelveInsight's, Plaque PsoriasisPipeline Insights, 2017, report provides comprehensive insights of the ongoing therapeutic research and development across Plaque Psoriasis. The report provides a complete understanding of the pipeline activities covering all clinical, preclinical and discovery stage products. A comparative pipeline therapeutics assessment of Plaque Psoriasis by development stage, therapy type, route of administration and molecule type is also covered in the report. It also has a special feature on the inactive pipeline products in this area.

The report is built using data and information sourced from proprietary databases, primary and secondary research and inhouse analysis by DelveInsights team of industry experts.

Secondary sources information and data has been collected from various printable and nonprintable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Scope of the report

The report provides a snapshot of the pipeline development for the Plaque Psoriasis
The report covers pipeline activity across the complete product development cycle i.e. clinical, preclinical and discovery stages for the Plaque Psoriasis
The report provides pipeline product profiles which includes product description, developmental activities, licensors collaborators and chemical information
Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Plaque Psoriasis
The report also covers the dormant and discontinued pipeline projects related to the Plaque Psoriasis

Reasons to Buy

Establish comprehensive understanding of the pipeline activity across this Plaque Psoriasis to formulate effective RD strategies
Gather information of the emerging competitors having potentially lucrative portfolio in this space and create effective counter strategies to gain competitive advantage
Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine
Plot corrective measures for pipeline projects by understanding the pipeline depth and focus of Plaque Psoriasis therapeutics
Devise in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Modify the therapeutic portfolio by identifying inactive projects and understanding the factors that might have halted their progress

Original Article: Plaque Psoriasis Pipeline Insight, 2017 [Report Updated: 31072017] Prices from USD $1250

NEXT ARTICLE

More From BioPortfolio on "Plaque Psoriasis Pipeline Insight, 2017 [Report Updated: 31072017] Prices from USD $1250"

Quick Search
Advertisement
 

Relevant Topics

Alzumab (Itolizumab)
Biocon Launches ALZUMAb™ - a ‘First in Class’ Novel Biologic Treatment for Psoriasis Patients in India • ALZUMAb™-World's first novel anti-CD6 antibody developed by Biocon to address a large unmet need for th...

Dermatology
Acne Dermatology Eczema Psoriasis Wound Care Dermatology is the medical specialty concerned with the diagnosis and treatment of skin disorders (Oxford Medical Dictionary). As well as studying how the skin works, dermatology covers...

Psoriasis
Psoriasis is a common skin condition affecting 2-3% of the population of the United Kingdom, where the skins replacement process is sped taking 2-6 days instead of the usual 21 - 28 days for the replacement of skin cells. Patients experience an accumulat...